IMPORTANCE Cognitive dysfunction is a common feature among patients with parkinsonism, including Parkinson disease (PD). However, there is a scarcity of data on cognitive functioning before parkinsonism diagnosis, a stage at which patients may still respond to putative disease-modifying interventions.
P oor cognitive functioning is common among patients with parkinsonism, and a substantial subgroup of patients has cognitive dysfunction at the time of parkinsonism diagnosis. Between 15% and 43% of patients with newly diagnosed Parkinson disease (PD) are cognitively impaired 1, 2 and cognitive impairment at diagnosis is a risk factor for subsequent dementia in patients with PD. 3 In patients with dementia with Lewy bodies (DLB), the dementia diagnosis typically precedes parkinsonism onset. In addition, poor cognitive functioning is common among patients with multiple system atrophy, progressive supranuclear palsy, and vascular parkinsonism. [4] [5] [6] Cognitive function has also been reported to be worse in individuals who are free of parkinsonism but have impaired olfaction and reduced dopamine transporter binding, both of which are strong proxies of PD. 7 Recently, a case-control study showed that subtle decline in executive cognitive functions may precede diagnosis in patients with PD, in parallel with subtle motor signs. 8 In addition, poor manual dexterity is associated with an increased risk of incident parkinsonism and PD, even when measured years before diagnosis. 9 However, it is unclear whether a single global assessment of cognitive functioning is associated with an increased risk of parkinsonism over longer intervals, to what extent the different cognitive domains predict parkinsonism, and how poor cognitive functioning combines with subtle motor signs in patients with prediagnostic parkinsonism. Such insight is critical because it may further unravel the prodromal phase of common parkinsonism diseases, in particular prodromal PD, a phase in which patients may still respond to putative diseasemodifying interventions.
We hypothesized that poor cognitive functioning is associated with an increased risk of parkinsonism and tested this hypothesis in a prospective, population-based study. Furthermore, we hypothesized that such an association would be especially driven by performance on tests of executive functions and that a combination of poor cognitive functioning and subtle motor signs would be a strong indicator of the probability for incident parkinsonism.
Methods
The present study was embedded in the Rotterdam Study, a large, prospective, population-based study in the Netherlands. 10, 11 In 1990, inhabitants of the well-defined
Ommoord district in the city of Rotterdam who were aged 55 years or older were invited to participate and 7983 individuals agreed (first subcohort). In 2000, all inhabitants who had become 55 years or older or had moved into the study district since the start of the study were invited to be included in the Rotterdam Study and 3011 agreed (second subcohort). The cohort was further extended in 2006 (third subcohort, age ≥45 years) to a total of 14 926 participants (overall response, 72.0%). By 2015, the first subcohort had a total of 6 visits (mean interval between visits, 8 years), the second subcohort had 3 visits, and the third subcohort had 2 visits.
The Rotterdam Study has been approved by the medical ethics committee according to the Population Study Act Rotterdam Study, executed by the Ministry of Health, Welfare, and Sports of the Netherlands. All participants provided written informed consent to participate in the study; participants did not receive financial compensation.
Although cognitive screening tests had been used since 1990, a more comprehensive cognitive test battery was introduced during center visit rounds between January 8, 2002 , and Of the original 14 926 participants, 8414 (56.4%) were alive at the time of and participated in this broader assessment, which is considered the baseline for the present study. Participants were extensively screened for parkinsonism and dementia 12, 13 and we excluded individuals who had parkinsonism or dementia at baseline as well as individuals who had missing data on more than 1 cognitive functioning task (n = 1028). We followed up the remaining 7386 participants until the onset of parkinsonism; onset of dementia; January 1, 2015; or death. Study follow-up for incident parkinsonism was virtually complete (98%). Table 1 lists the domain that is primarily represented by each test. Of these domains, executive abilities, information processing speed, attention, and semantic fluency are commonly impaired in patients with clinical PD, including in those with PD and mild cognitive impairment.
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Furthermore, impairment in semantic fluency is associated with a subsequent risk of dementia in patients with PD.
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Assessment of Manual Dexterity
We used the Purdue Pegboard Test to assess manual dexterity.
24
In this test, participants are asked to place as many cylindrical metal pegs into 1 of 25 holes in a pegboard as possible in 30 seconds. The test is performed 3 times, 1 each using the left hand, right hand, and then both hands simultaneously. The mean Purdue Pegboard Test score is the sum of each trial divided by 3.
Assessment of Parkinsonism
A detailed description of parkinsonism assessment methods in the Rotterdam Study has been published. 25 In the present study, we used 4 overlapping modalities to screen for potential parkinsonism: in-person examinations, in-person interviews, use of antiparkinson medication, and clinical monitoring alerts. In-person examinations comprised 2 phases. In the first phase, participants underwent standardized assessments of the following parkinsonian signs: tremor (resting, positional, and intentional), hypokinesia and bradykinesia (including arm swing, gait, finger tapping, and general impression), cogwheel rigidity, and postural reflex. These screening assessments were conducted by research nurses who were repeatedly trained by one of us, an experienced neurologist (P.J.K.) during the study period. Individuals who had positive screening results were subsequently invited for a structured physical examination by a research physician who specialized in neurologic diseases.
Of all individuals who had positive screening results in any of these methods, complete medical records (including letters from medical records of specialists and general practitioners) were studied and case reports were prepared covering all potentially relevant information to establish the presence and cause of parkinsonism. These case reports were evaluated by a panel led by the experienced neurologist (P.J.K.).
Parkinsonism was defined as (1) the presence of hypokinesia or bradykinesia in combination with at least 1 other cardinal sign (resting tremor, rigidity, or postural imbalance) as observed by any physician and/or (2) a clinical diagnosis of parkinsonism by a neurologist or geriatrician (if motor examination details were not available). 
Assessment of Probable PD
A detailed description of PD assessment methods in the Rotterdam Study has previously been published. 25 Parkinson disease was diagnosed after exclusion of parkinsonism associated with preexistent dementia, use of antidopaminergic drugs, cerebrovascular disease, multiple system atrophy, progressive supranuclear palsy, and evidence for other rare causes (eg, corticobasal degeneration). To diagnose PD, there also had to be (1) a clinical PD diagnosis by a neurologist or geriatrician and/or (2) a positive response to dopaminergic treatment. During the study period (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) , dementia at parkinsonism diagnosis was used as an exclusion criterion for PD by the neurologists who examined patients and adjudicated case reports in the Rotterdam Study protocol. As a consequence, there were 9 patients with parkinsonism with a clinical presentation consistent with PD who were not originally classified as having PD because their parkinsonism was preceded by a dementia diagnosis. At the time of diagnosis these patients did not have typical clinical features of DLB, such as visual hallucinations or pronounced variations in attention and alertness, or a clear secondary cause of parkinsonism. In the recent Movement Disorder Society criteria of PD, 26 prior dementia is no longer an exclusion criterion for PD, suggesting that these patients would now likely receive a clinical PD diagnosis. Therefore, we classified these 9 patients together with those who had already received a clinical PD diagnosis (n = 48) as having probable PD.
Assessment of Dementia
A detailed description of assessment methods has previously been published. 27 In short, participants were screened for dementia at baseline and follow-up examinations using a 3-step protocol. 13 
Definition of Cognitive Dysfunction and Subtle Motor Features
Because this was a population-based study, we used internal age-and sex-specific norms in the full cohort to determine the presence of cognitive dysfunction. Age-and sex-specific norms of cognitive test scores in the Rotterdam Study have previously been published. 15 Cognitive dysfunction was defined as age-and sex-adjusted global cognition z scores of less than −1. Subtle motor features were defined as any parkinsonian sign during screening or Purdue Pegboard Test z score less than −1 compared with age-and sex-specific internal norms.
Statistical Analysis
Statistical methods are presented in full in the eMethods in the Supplement. In short, we performed a principal component analysis of 4 tests (Stroop color word test, letter-digit substitution, verbal fluency, and word learning) to derive a global cognition score. We studied the association of cognitive function test scores with incident all-cause parkinsonism and incident probable PD using Cox proportional hazards models with adjustment for age, sex, and study subcohort.
To enable translation of our findings to clinical practice, we present likelihood ratios (LRs) for the baseline presence of isolated or combined cognitive dysfunction and subtle motor features for incident parkinsonism during follow-up. Furthermore, we consecutively subtracted 1 year of follow-up in a stepwise fashion to explore whether the LRs of combined cognitive dysfunction and subtle motor features at baseline for incident parkinsonism during follow-up varied by duration of follow-up. To determine statistical significance, we used 2-tailed tests with the threshold set to α = .05. Data analysis was conducted with SPSS, version 23.0.0.0 (IBM Corp) and R, version 3.2.4 (R Foundation).
Results
Baseline characteristics of the study population are reported in Table 2 . Individuals with at least 1 parkinsonian sign had lower Purdue Pegboard Test scores compared with other individuals (age-and sex-adjusted difference in Purdue Pegboard Test z score, 0.25 [95% CI, 0.20-0.31]; P < .001). In individuals without any parkinsonian sign, cognitive dysfunction was associated with lower scores on the Purdue Pegboard Test (age-and sex-adjusted difference in Purdue Pegboard Test z score, 0.48 [95% CI, 0.42-0.54]; P < .001).
During follow-up, 7386 participants amassed 61 660 person-years (median, 8.3 years; range, 0-15 years) and 79 (1.1%) participants received a diagnosis of incident parkinsonism. Of those with incident parkinsonism, 24 (30.4%) also received a diagnosis of incident dementia (10 before and 14 after onset of parkinsonism), and 446 (6.1%) individuals who remained free of incident parkinsonism received a diagnosis of incident dementia. The median interval between baseline cognitive assessment and detection of incident parkinsonism was 5.6 years. Fifty-four (68.4%) patients received a diagnosis of incident parkinsonism without a structured physical examination by a research physician, whereas 13 (16.5%) patients received a diagnosis without a diagnostic examination by a neurologist or geriatrician. Overall, 8 (10.1%) patients had neither type of examination; these patients received the diagnosis from a general practitioner or nursing home physician. Of patients with incident parkinsonism, 57 (72.2%) received a diagnosis of probable PD. A complete overview of clinical parkinsonism diagnoses is presented in eTable 1 in the Supplement.
Poor global cognition at baseline was associated with a higher risk of incident parkinsonism (hazard ratio [HR] The association between poor cognitive functioning and incident parkinsonism remained robust beyond the first 8 years after censoring individuals with incident dementia and restricting the analysis to patients with incident parkinsonism who were examined by a neurologist or geriatrician ( Figure 1) . Additional adjustment for educational attainment did not affect the association between poor cognitive functioning and incident parkinsonism (HR 1.81; 95% CI, 1.37-2.38). The association slightly weakened after additional adjustment for subtle motor signs (HR, 1.69; 95% CI, 1.38-2.34) (Figure 1 ). The association attenuated somewhat and was no longer statistically significant after exclusion of individuals with subtle motor signs at baseline (HR, 1.33; 95% CI, 0.92-1.92). Poor cognitive functioning was also associated with probable PD (HR, 1.52; 95% CI, 1.10-2.08) and with a joint end point of probable PD or DLB (HR, 1.59; 95% CI, 1.17-2.17).
With respect to the separate cognitive function tests, letterdigit substitution test, Stroop color word test tasks 2 and 3, verbal fluency, and immediate 15-word list learning test scores were significantly associated with all-cause parkinsonism, each with an HR exceeding 1.3 per SD decrease (Table 1) . For probable PD, effect estimates were generally direction consistent but somewhat attenuated and not statistically significant, with the exception of verbal fluency (Table 1) .
Almost half (49.4%) of participants who received a diagnosis of incident parkinsonism during follow-up already had subtle motor features at baseline, cognitive dysfunction at baseline, or both. As reported in Table 3 , individuals with cognitive dysfunction at baseline had an almost doubled risk of incident parkinsonism compared with individuals with normal cognitive functioning. Those who had both cognitive dysfunction and subtle motor signs had a 3.3-fold increased risk of incident parkinsonism at baseline. This finding translates to a moderately increased posttest probability of developing incident parkinsonism for individuals who had both features at baseline (positive LR, 2.66; 95% CI, 1.64-4.32), and the positive LR increased further after follow-up was restricted to shorter intervals (Figure 2) . When a stricter threshold for cognitive dysfunction and low manual dexterity was used (−2 or less z score), the positive LR of combined cognitive dysfunction and subtle motor features at baseline also increased (Table 3) .
Of 1181 individuals with cognitive dysfunction at baseline, 486 (41.2%) also had subtle motor signs at baseline, including most (14 of 22 [63.6%]) of those who received a diagnosis of both incident parkinsonism and incident dementia (eTable 2 in the Supplement). In individuals who received a diagnosis of both incident dementia and incident parkinsonism, baseline cognitive dysfunction was not associated with incident dementia (HR, 1.10; 95% CI, 0.43-2.80).
Mini-Mental State Examination
The MMSE was not included in the main analyses because it is less sensitive to subtle cognitive deficits than the other cognitive function tests. Still, lower total MMSE scores were associated with a higher risk of incident all-cause parkinsonism and nonsignificantly with incident probable PD (eTable 3 in the Supplement). The pentagon copy item of the MMSE was also associated with an increased risk of incident all-cause parkinsonism and nonsignificantly with incident probable PD. Inclusion of the pentagon copy in global cognition did not substantially affect its association with incident parkinsonism (eTable 3 in the Supplement).
Discussion
In this prospective, population-based cohort, poor cognitive functioning was associated with an increased risk of parkinsonism. This association was present even after restricting the analysis to patients with incident parkinsonism without dementia. The association was also present for diverse domains of cognition, including executive, attention, cognitive speed, and memory domains. Our findings suggest that cognitive dysfunction can be considered a sign of prodromal PD.
We observed that poor cognitive functioning is prospectively associated with parkinsonism when analyses were restricted to patients with probable PD. Our data provide important insight into the association of cognitive functioning with incident parkinsonism in the general population, especially given the fact that, to our knowledge, only 2 communitybased studies have previously published data on this topic.
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In the Honolulu-Asia Aging Study of Japanese American men, an increased risk of PD was seen across quartiles of worse executive function as well as an increased risk with slow reaction time; however, the full study results have not yet been published. 33 In the Religious Orders Study and Memory and Aging Project, associations between several cognitive function tests and incident parkinsonism (without diagnosis of PD vs atypical parkinsonism) were reported in an elderly population with 5-year follow-up. 34 Separately, in a cross-sectional study of parkinsonism-free individuals, participants with strong PD proxies (hyposmia and dopamine transporter binding reduction) had worse global cognition than did other participants and particularly performed worse on tasks relating to fluency, task switching, attention, and working memory. 7 The observations in these 3 studies are consistent with our findings: we noted strong associations between incident parkinsonism and test scores relating to fluency and moderate associations with processing speed, reading speed, interference of automated processing and attention, and recognition from verbal memory. These results are also in line with the observation that nonamnestic impairment is more common than amnestic impairment in patients with clinical PD with mild cognitive impairment. Associations of separate cognitive function tests with probable PD were generally direction consistent. However, with the exception of verbal fluency and the word learning recognition task, HRs were lower for probable PD than for all-cause parkinsonism. Also, most associations of separate cognitive function tests with probable PD were statistically nonsignificant; this finding may be due to the relatively small number of incident probable PD cases and the fact that the tests used were not designed specifically to detect cognitive dysfunction in PD. 35 We consider 3 explanations for an observed link between poor cognitive performance and incident parkinsonism. The first would be that parkinsonism only precedes cognitive dysfunction. This is an unlikely explanation for our results. We actively screened for parkinsonism and dementia at baseline and excluded individuals with baseline parkinsonism and dementia. Furthermore, the association remained robust beyond the first 8 years, making it unlikely that our findings were driven by a delay in parkinsonism diagnosis. The second explanation would be that individuals who probably will develop parkinsonism in mid-or late life never attain a high level of cognitive functioning in early life. However, adjustment for educational level did not affect the association between cognitive functioning and incident parkinsonism in our population. Still, because educational attainment is only a proxy of early life cognitive functioning, we cannot exclude this explanation. Third, low baseline cognitive scores may indicate ongoing cognitive decline in prediagnostic patients who probably will develop parkinsonism, most of whom have prediagnostic PD. Consistent with this explanation is the high proportion (30.4%) of patients with incident parkinsonism who also received a diagnosis of incident dementia during followup, either before or after parkinsonism diagnosis. Almost half of the patients who had a diagnosis of incident parkinsonism during follow-up already had some cognitive dysfunction, subtle motor features at baseline, or both. These findings suggest that both motor and cognitive decline are common in patients with prodromal PD and that their sequence of occurrence is variable. Future observational studies will unravel the underlying abnormalities that drive the variable sequence of motor and cognitive decline in patients with prodromal PD. In the Movement Disorder Society criteria for prodromal PD, cognitive loss was not included as a variable because of the absence of prospective evidence of predictive value. 36 Our results, as well as those of other published studies, suggest that cognitive dysfunction now warrants inclusion as a prodromal marker. Although subtle motor abnormalities and cognitive dysfunction often occur in the same individuals, their predictive utility for incident parkinsonism only slightly overlaps. In the present study, having a global cognitive score 1 SD below the mean would be associated with a positive LR of 1.97 for parkinsonism, whereas normal cognition would translate to a negative LR of 0.86, and a combination of cognitive dysfunction and subtle motor signs was an even stronger predictor for parkinsonism. The predictive value further increased for more stringent thresholds of cognitive and subtle motor dysfunction and also for shorter prediction intervals. The correlation between subtle motor features and cognitive dysfunction will likely also be taken into account in risk estimates for the next Movement Disorder Society criteria for prodromal PD.
Limitations and Strengths
Before further interpreting these findings, several methodologic considerations should be noted. First, it is possible that some misclassification of the diagnosis of parkinsonism occurred. However, after restricting our analyses to patients who were examined by neurologists or geriatricians, we observed a similar overall association. Furthermore, we classified patients who had a clinical presentation consistent with PD as having probable PD irrespective of whether and when they also developed dementia. This categorization was done to be consistent with the 2015 Movement Disorder Society clinical diagnostic criteria for PD 26 in which PD and DLB are also no longer considered mutually exclusive diagnoses. It is likely that many of these patients would also have met criteria for DLB once additional features developed. However, the removal of early dementia as an exclusion criterion for PD diagnosis remains a highly debated issue with opposing viewpoints.
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Strengths of our study include its population-based design, which ensures a representative sample of unselected patients with incident parkinsonism, active screening for parkinsonism and dementia at baseline, complete access to medical records of study participants (including specialists' letters), and the extensive (median, 8 years) follow-up for incident parkinsonism. This study extends findings from the Rotterdam Study's recently published nested case-control study, 8 in which we showed that poor executive functioning and subtle motor signs are increasingly more common among patients with prodromal PD. Although our previous publication documented the temporal association, it could not be used to estimate risk with a single measure, which is needed to further refine diagnostic criteria for prodromal PD. 36 In the present project, we used a prospective design based on a single global cognitive function measure, which allowed us to assess how common poor cognitive functioning is in patients with prodromal parkinsonism, both in isolation and in combination with subtle motor features.
Conclusions
Poor cognitive functioning is associated with an increased risk of developing all-cause parkinsonism and probable PD, even at intervals longer than 8 years. The association is present for diverse domains of cognition, including executive, attention, cognitive speed, and memory domains. Our findings suggest that poor cognitive functioning can be considered a prodromal sign of PD. Likelihood ratios (LRs) for incident parkinsonism by decreasing follow-up duration. comprised several tasks, we only used data from the most complicated task of each (i.e., the interference task for Stroop and the 15 minute delayed recall task for WLT) in calculating the g factor to prevent highly correlated tasks distorting factor loadings in the principal component analysis. Contrary to our previous work, 4 we did not include the Purdue Pegboard test in the g factor, since it is strongly influenced by motor function and was previously already shown to predict incident parkinsonism in this population. 5 We studied the association of cognitive function test scores with incident parkinsonism using Cox proportional hazards models, with adjustment for age, sex and study subcohort. In sensitivity analyses, we repeated the main analysis after: 1) exclusion of the first five years of follow up; 2) exclusion of individuals with subtle motor features at baseline (any parkinsonian sign during screening or < 1 Purdue Pegboard z score compared to internal age and sex specific norms); 3) censoring (i.e. treating these individuals as not having incident parkinsonism) patients with incident dementia preceding parkinsonism (censored at time of dementia diagnosis); 4) censoring patients who were not diagnosed by a neurologist or geriatrician; 5) restriction to probable PD patients. Furthermore, in other sensitivity analyses, we explored whether an association between cognitive performance and incident parkinsonism in mid or late life may be reflective of early life cognitive performance by additionally adjusting the main model for level of education, and separately assessed effect modification by age, gender or study subcohort by introducing one by one interaction terms with global cognition.
To enable translation of our findings to clinical practice, we also present likelihood ratios (LRs) for the baseline presence of isolated or combined cognitive dysfunction and subtle motor features (any parkinsonian sign or low Purdue Pegboard score) for incident parkinsonism during follow up. We used two different thresholds to define cognitive dysfunction and low Purdue Pegboard score (< 1 and < 2 z score compared to internal age &sex specific norms).
Furthermore, we consecutively subtracted 1 year of follow up in a step wise fashion to explore whether the LRs of combined cognitive dysfunction and subtle motor features (at baseline), for incident parkinsonism during follow up, varied by duration of follow up. Of note, since the Rotterdam Study is a population based study, we used internal age and sex specific norms in the full cohort to determine the presence of cognitive dysfunction. Age and sex specific norms of cognitive test scores in the Rotterdam Study have previously been published 4 The MMSE was not included in the main analyses because it is less sensitive to cognitive performance than the separate cognitive function tests, in large part due to ceiling effects. Still, since the MMSE is easily applied clinically, we also studied the association of total MMSE score with incident all cause parkinsonism and incident probable PD, and repeated the main analyses of Global cognition after incorporation of the total MMSE score. As visuospatial impairment is a common sign in clinical PD, we separately repeated these sensitivity analyses using the copy item of the MMSE only.
155 study participants (2%) did not complete one cognitive functioning task; to avoid selective loss of data, we performed multiple imputation using the mean of five imputations, based on educational attainment, other test scores, incident dementia status, and incident parkinsonism status. The distribution of test scores before and after imputation was similar. 
All parkinsonism diagnoses 79 [100]
Unspecified parkinsonism denotes parkinsonism patients that did not have any of the above clinical diagnoses. N, number of individuals with diagnosis during follow up.
